Table 1.
Patient characteristic
| Characteristic |
Patients with mCRC |
Healthy Individuals (HI) |
|---|---|---|
| N | 219 | 114 |
| Age, y | ||
| Median (range) | 61 (37–77) | 41 (19–69) |
| Missing data | 96 | |
| Sex | ||
| Male (%) | 73 (58,9) | 59 (51,8) |
| Female (%) | 51 (41,1) | 55 (48,2) |
| missing data | 95 | |
| Location of primary tumor | ||
| Right colon (%) | 34 (27,9) | |
| Left colon (%) | 88 (72,1) | |
| Missing data | 97 | |
| Primary tumor in place | ||
| Yes (%) | 96 (78) | |
| No (%) | 27 (22) | |
| Missing data | 96 | |
| Number of metastatic sites | ||
| Median (range) | 2 (1–4) | |
| 1 (%) | 51 (44,3) | |
| >1 (%) | 64 (55,6) | |
| Missing data | 104 | |
| Limited liver disease | ||
| Yes (%) | 45 (36,3) | |
| No (%) | 79 (63,7) | |
| Missing data | 95 | |
| Leukocytes cell count (G/L) | ||
| Median (range) | 8 (3,93–27,33) | |
| Missing data | 104 | |
| LDH level (U/L) | ||
| Median (range) | 315,5 (148–4502) | |
| Missing data | 123 | |
| CEA level (ng/mL) | ||
| Median (range) | 41,7 (0,70–14034) | |
| Missing data | 107 | |
| Platelet count (G/L) | ||
| Median (range) | 314 (116–849) | |
| Missing data | 152 | |
| Creatinine clearance (mL/min) CKD | ||
| Median (range) | 93,5 (44–120) | |
| Missing data | 155 | |
CEA, carcinoembryonic antigen; LDH, Lactate dehydrogenase; mCRC, metastatic colorectal cancer.